1. The low doses of SWCNTs affect the expression of proliferation and apoptosis related genes in normal human astrocytes
   Olha V. Rudnytska et al, 2021, Current Research in Toxicology CrossRef
2. The insulin‐like growth factor binding protein‐3 and its death receptor in pancreatic ductal adenocarcinoma poor prognosis
   Ali Gheysarzadeh et al, 2019, Journal of Cellular Physiology CrossRef
3. Testis‐specific protein, Y‐linked 1 activates PI3K/AKT and RAS signaling pathways through suppressing IGFBP3 expression during tumor progression
   Wenling Tu et al, 2019, Cancer Science CrossRef
4. Producción de las proteínas de unión al factor de crecimiento insulinoide durante el desarrollo de la fibrosis hepática por hepatitis C crónica
   D. Rosique-Oramas et al, 2020, Revista de Gastroenterología de México CrossRef
5. Production of insulin-like growth factor-binding proteins during the development of hepatic fibrosis due to chronic hepatitis C
   D. Rosique-Oramas et al, 2020, Revista de Gastroenterología de México (English Edition) CrossRef
6. Fluoroquinolones upregulate insulin-like growth factor–binding protein 3, inhibit cell growth and insulin-like growth factor signaling
   Chih-Ling Chung et al, 2024, European Journal of Pharmacology CrossRef
7. Noninvasive Biomarkers for the Diagnosis of Liver Fibrosis and Cirrhosis
   Dorothy Rosique-Oramas et al, 2019, Liver Cirrhosis - Debates and Current Challenges CrossRef
8. Silencing of NAMPT leads to up-regulation of insulin receptor substrate 1 gene expression in U87 glioma cells
   Daria O. Tsymbal et al, 2020, Endocrine Regulations CrossRef
9. Insulin-Like Growth Factor (IGF) System in Liver Diseases
   Agnieszka Adamek et al, 2018, International Journal of Molecular Sciences CrossRef
10. IGFBP‐3 and TGF‐β inhibit growth in epithelial cells by stimulating type V TGF‐β receptor (TβR‐V)‐mediated tumor suppressor signaling
    Chun‐Lin Chen et al, 2021, FASEB BioAdvances CrossRef
11. Clinicopathological correlation of insulin-like growth factor binding protein 3 and their death receptor in patients with gastric cancer
    Amir Ansari et al, 2024, Research in Pharmaceutical Sciences CrossRef
12. Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotherapy
    Sohel M. Julovi et al, 2018, Frontiers in Endocrinology CrossRef
13. The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance
    Mai-Huong Thi Ngo et al, 2021, International Journal of Molecular Sciences CrossRef
14. Differential production of insulin-like growth factor-binding proteins in liver fibrosis progression
    Moisés Martínez-Castillo et al, 2020, Molecular and Cellular Biochemistry CrossRef
15. Clinical significance of serum IGFBP‐3 in colorectal cancer
    Yu‐Lei Hou et al, 2019, Journal of Clinical Laboratory Analysis CrossRef
16. IGFBP3 Enhances Treatment Outcome and Predicts Favorable Prognosis in ABC-DLBCL
    Han-Bing Li et al, 2023, Journal of Oncology CrossRef
17. Construction and validation of a novel IGFBP3-related signature to predict prognosis and therapeutic decision making for Hepatocellular Carcinoma
    Jianlin Chen et al, 2023, PeerJ CrossRef